Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Servings Per Container: 31
Gastrointestinal adverse events with GLP-1 receptor agonists for obesity: a systematic review
The SUSTAIN and STEP clinical programs documented a consistent set of side effects across test groups, most of which affected the gastrointestinal system
For injectable semaglutide (Ozempic, Wegovy) and other GLP-1 receptor agonists, taste disturbances are not specifically highlighted among the most common adverse effects, though gastrointestinal symptoms that might indirectly affect taste perception are well-documented
A GLP-1 agonist like semaglutide activates one receptor to suppress appetite and improve blood sugar
US$ 21.31
US$ 28.55
US$ 21.80
US$ 25.68
US$ 27.08
US$ 24.74
